Evidence map›Paper›PMID 34644469›Full record

ArticleThe New England journal of medicine2021

Convalescent Plasma for Outpatients with Covid-19. Reply.

Frederick K Korley, Valerie Durkalski-Mauldin, Clifton W Callaway

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in The New England journal of medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Frederick K KorleyUniversity of Michigan, Ann Arbor, MI.
Valerie Durkalski-MauldinMedical University of South Carolina, Charleston, SC.
Clifton W CallawayUniversity of Pittsburgh, Pittsburgh, PA callawaycw@upmc.edu.

Funding

ACTIV Integration of Host-targeting Therapies for COVID-19 Administrative Coordinating CenterOT2HL156812 · NHLBI · RESEARCH TRIANGLE INSTITUTE · PI NOLEN, TRACY L, THOMAS, SONIA M · 2020 to 2024
$1270.7M
Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) - Clinical Coordinating Center (CCC)U24NS100659 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WILLIAM G BARSAN, Clifton W. Callaway · 2017 to 2026
$6.4M
Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) - Data Coordinating CenterU24NS100655 · NINDS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI VALERIE L DURKALSKI, Sharon Dziuba Yeatts · 2017 to 2026
$4.4M
The OHSU SIREN Network Enrollment Hub RenewalU24NS100657 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI MOHAMUD RAMZANALI DAYA, Bory Kea · 2017 to 2026
$2.4M
NHLBI NIH HHS OT2 HL156812NINDS NIH HHS U24 NS100655NINDS NIH HHS U24 NS100657NINDS NIH HHS U24 NS100659
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19OutpatientsCOVID-19 SerotherapyHumansImmunization, PassiveSARS-CoV-2Treatment Outcome

Identifiers

PMID34644469
PMCPMC11723561

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.